Rho-GTPase signaling, which includes Ras-related C3 botulinum toxin substrate 1 (Rac1) as a major regulator, is involved in cancer progression and chemoresistance; however, the role of Rac1 in MM remains elusive. This evidence concerns the gene RAC1 and Miyoshi myopathy.